CATTRINI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 3.589
AS - Asia 390
NA - Nord America 171
SA - Sud America 39
AF - Africa 8
Totale 4.197
Nazione #
IT - Italia 3.505
SG - Singapore 168
US - Stati Uniti d'America 160
CN - Cina 101
VN - Vietnam 83
FR - Francia 25
FI - Finlandia 23
BR - Brasile 22
HK - Hong Kong 12
AR - Argentina 8
DE - Germania 7
GB - Regno Unito 7
JP - Giappone 6
MX - Messico 6
ES - Italia 4
PE - Perù 4
CA - Canada 3
IN - India 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AL - Albania 2
BD - Bangladesh 2
CO - Colombia 2
ID - Indonesia 2
IE - Irlanda 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
PY - Paraguay 2
UA - Ucraina 2
BH - Bahrain 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GR - Grecia 1
IQ - Iraq 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RE - Reunion 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.197
Città #
Genova 1.557
Genoa 1.280
Rapallo 337
Vado Ligure 312
Singapore 82
San Jose 61
Ashburn 25
Lauterbourg 24
Helsinki 23
Ho Chi Minh City 23
Beijing 19
Hanoi 18
Council Bluffs 11
Hong Kong 11
New York 10
Santa Clara 6
Frankfurt am Main 5
Mexico City 5
Tokyo 5
City of London 3
Los Angeles 3
Ân Thi 3
Biên Hòa 2
Bordighera 2
Can Tho 2
Cape Town 2
Dublin 2
Jakarta 2
Madrid 2
Montreal 2
Nantong 2
Nuremberg 2
Rome 2
Shanghai 2
Tianjin 2
Tirana 2
Verona 2
Vilnius 2
Addis Ababa 1
Agropoli 1
Amman 1
Amsterdam 1
Aquidauana 1
Armavir 1
Athens 1
Atlanta 1
Barquisimeto 1
Bitonto 1
Bogotá 1
Buenos Aires 1
Bắc Ninh 1
Bến Cầu 1
Campagnano di Roma 1
Canoas 1
Cao Lanh 1
Cardiff 1
Casablanca 1
Catamarca 1
Cebu City 1
Chalco 1
Chicago 1
Cidade Ocidental 1
Ciudad del Este 1
Comodoro Rivadavia 1
Copenhagen 1
Curitiba 1
Da Nang 1
Dammam 1
Diego Martin 1
Divinópolis 1
Durban 1
Elmwood Park 1
Embu das Artes 1
Erbil 1
Fatehgarh 1
Greensboro 1
Guangzhou 1
Guarulhos 1
Haiphong 1
Honolulu 1
Houston 1
Hải Dương 1
Iguape 1
Jeddah 1
Kathmandu 1
Kuwait City 1
La Plata 1
Lima 1
Lisbon 1
Ljubljana 1
Long An 1
Long Xuyen 1
Macaé 1
Manama 1
Milan 1
Minas Novas 1
Mumbai 1
Mymensingh 1
Naples 1
Ninh Bình 1
Totale 3.917
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 244
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer 206
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 195
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 189
A hnRNP K–AR-related signature reflects progression toward castration-resistant prostate cancer 188
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 182
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 179
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer 175
Genitourinary tumours in the targeted therapies era: New advances in clinical practice and future perspectives 166
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 165
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 165
Bone metastases from prostate cancer: hormonal therapy 158
Immunotherapy for genitourinary cancer: State of the art and new perspectives 158
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 147
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 143
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone 140
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 139
Lipidomic profiling in patients with metastatic castration-resistant prostate cancer (mCRPC) 137
Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study 136
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 135
Atezolizumab and bladder cancer: facing a complex disease 123
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience 123
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 120
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS 118
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 104
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer 104
Combination therapy in metastatic renal cell carcinoma: Back to the future? 100
Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States 97
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty? 52
null 40
Totale 4.328
Categoria #
all - tutte 14.172
article - articoli 13.351
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 467
Totale 27.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 50 23 29
2021/2022344 15 10 16 30 16 40 7 85 25 35 25 40
2022/2023388 28 47 3 37 79 55 0 30 50 7 47 5
2023/2024306 10 63 8 43 10 55 12 8 10 16 11 60
2024/2025830 30 47 26 72 88 75 94 176 16 34 89 83
2025/20261.130 169 18 185 80 190 63 178 51 74 122 0 0
Totale 4.328